The ribonucleoprotein telomerase is responsible for maintaining the length
of telomeric ends of chromosomes in tumour cells. It is activated in over 8
5% of the tumour cells, and is emerging as a major target for cancer chemot
herapy. A range of molecules containing tricyclic and tetracyclic aromatic
chromophores has been shown to inhibit the telomerase enzyme system at the
micromolar level. There is evidence that they do so via stabilisation of a
guanine-quadruplex structure, which provides a stop signal for further telo
mere elongation. The known structure-activity relationships for these compo
unds are summarised, and pointers for the development of future molecules w
ith enhanced selectivity are described. (C) 2000 Elsevier Science Inc. All
rights reserved.